Viewing nowJinfrag Tablets (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 200703737 · Notified 2007.03.30 · Insurance code 650301310
Improvement of ischemic symptoms in chronic arterial occlusive disease (ulcers, pain)
This medication is used to improve ischemic symptoms such as ulcers, pain, and cold sensitivity caused by chronic arterial occlusive disease, Buerger's disease, obliterative atherosclerosis, and diabetic peripheral vascular disease.
As Sarpogrelate Hydrochloride, take 100 mg orally three times a day after meals. Adjust dosage as needed based on symptoms.
This drug should not be used in patients with bleeding disorders as it may worsen bleeding. It is advisable not to administer to pregnant women or women who may become pregnant, as it may be harmful to the fetus. Caution should be exercised in patients who are menstruating or have a tendency to bleed as the risk of bleeding may be increased. Patients taking anticoagulants or antiplatelet agents may have an increased risk of bleeding, and thus careful administration is necessary. Patients with severely impaired kidney function may be affected by the drug's elimination and require caution. Elderly patients may have reduced kidney and liver function leading to increased drug concentrations, and thus starting at a lower dose and careful observation of their condition is necessary. During the use of this drug, regular blood tests are required as symptoms of bleeding, liver function abnormalities, or various blood reactions may appear. Rarely, various side effects such as skin rash, itching, vomiting, abdominal pain, drowsiness, headache, proteinuria, etc., may occur, and if any abnormal symptoms arise, immediate consultation with a healthcare professional is necessary. The safety of this drug has not been established in children, and it is advisable not to use it in this age group. Keep this medication out of reach of children and do not transfer it to another container to maintain its quality and safety.
Bleeding tendency (gastrointestinal bleeding, intracranial hemorrhage, subcutaneous bleeding), blood disorders (agranulocytosis, anemia, thrombocytopenia, leukopenia), liver abnormalities (acute hepatitis, liver dysfunction, jaundice), hives
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature.
White round film-coated tablets
(Domestic) 30 tablets/bottle, 300 tablets/bottle (Export) 30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.